AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 182 filers reported holding AXSOME THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.22 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,500,371 | -2.7% | 50,084 | 0.0% | 0.02% | -3.8% |
| Q2 2023 | $3,599,036 | -33.3% | 50,084 | -47.3% | 0.03% | -29.7% |
| Q1 2023 | $5,398,114 | -59.2% | 95,084 | -44.5% | 0.04% | -58.4% |
| Q4 2022 | $13,225,170 | +168.5% | 171,474 | +55.3% | 0.09% | +154.3% |
| Q3 2022 | $4,925,000 | +11.7% | 110,380 | -4.1% | 0.04% | -2.8% |
| Q2 2022 | $4,408,000 | -7.5% | 115,084 | 0.0% | 0.04% | +12.5% |
| Q1 2022 | $4,763,000 | +33.6% | 115,084 | +22.0% | 0.03% | +39.1% |
| Q4 2021 | $3,565,000 | -29.6% | 94,357 | -38.6% | 0.02% | -32.4% |
| Q3 2021 | $5,063,000 | -36.7% | 153,602 | +29.5% | 0.03% | -38.2% |
| Q2 2021 | $8,001,000 | -11.7% | 118,602 | +2.4% | 0.06% | -26.7% |
| Q1 2021 | $9,062,000 | -4.0% | 115,802 | 0.0% | 0.08% | 0.0% |
| Q4 2020 | $9,435,000 | +31.8% | 115,802 | +15.3% | 0.08% | +11.9% |
| Q3 2020 | $7,157,000 | – | 100,455 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 1,009,799 | $82,268,000 | 41.24% |
| Fairmount Funds Management LLC | 220,098 | $17,931,000 | 6.41% |
| WMS Partners, LLC | 250,000 | $20,368,000 | 3.51% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 2,064,158 | $168,167,000 | 3.06% |
| MORGAN JESS S & CO INC | 44,468 | $3,623,000 | 2.88% |
| RTW INVESTMENTS, LP | 1,672,416 | $136,252,000 | 2.29% |
| RA Capital Management | 1,655,447 | $134,869,000 | 1.88% |
| Nicholas Investment Partners, LP | 207,452 | $16,901,000 | 1.30% |
| Affinity Asset Advisors, LLC | 25,000 | $2,037,000 | 1.08% |
| Parkman Healthcare Partners LLC | 30,758 | $2,506,000 | 0.64% |